• 14 May, 2025

SC halts Glenmark from selling copies of Merck's diabetes drugs

May 18, 2015 | Monday | News | By BioSpectrum Bureau

SC halts Glenmark from selling copies of Merck's diabetes drugs

(Photo Courtesy: www.corupriesthood.com)

(Photo Courtesy: www.corupriesthood.com)

The SC has, however, allowed Glenmark to sell its existing stocks of these two drugs.

The judgment brings a great relief to Merck after two years, when in 2013 it sued its opponent for infringing its patent on the compound sitagliptin, which is present in both the drugs.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Can India take on a larger role in the global biosimilars market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy